Market Analysis and Insights:
The global Preclinical CRO market size is projected to reach US$ 23,381 million by 2028, from US$ 13,017 million in 2021, at a CAGR of 8.27% during 2022-2028.
Fully considering the economic change by this health crisis, Bioanalysis and DMPK Studies accounting for 46.53% of the Preclinical CRO global market in 2021, is projected to value US$ 11,059 million by 2028, growing at a revised 8.60% CAGR in the post-COVID-19 period. While Pharmaceutical Companies segment is altered to an 8.06% CAGR throughout this forecast period.
China Preclinical CRO market size is valued at US$ 3,084 million in 2021, while the North America and Europe Preclinical CRO are US$ 5,966 million and US$ 2,124 million, severally. The proportion of the North America is 45.83% in 2021, while China and Europe are 23.69% and 16.32% respectively, and it is predicted that China proportion will reach 28.43% in 2028, trailing a CAGR of 10.69% through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR 5.56%, 5.98%, and 8.21% respectively for the next 6-year period. As for the Europe Preclinical CRO landscape, Germany is projected to reach US$ 874 million by 2028 trailing a CAGR of 5.94% over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical CRO market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical CRO market.
Scope and Market Size:
Preclinical CRO market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.
By Company
- Charles River
- Wuxi AppTec
- Labcorp
- Eurofins Scientific
- PPD
- ICON Plc
- Pharmaron
- Inotiv
- ChemPartner
- JOINN Lab
- EVOTEC
- Medicilon
- Crown Bioscience
- Champion Oncology
Segment by Type
- Bioanalysis and DMPK Studies
- Toxicology Testing
- Safety Pharmacology
- Others
Segment by Application
- Pharmaceutical Companies
- Medical Device Companies
- Other
By Region
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Preclinical CRO Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
- 1.2.2 Bioanalysis and DMPK Studies
- 1.2.3 Toxicology Testing
- 1.2.4 Safety Pharmacology
- 1.2.5 Other
- 1.3 Market by Application
- 1.3.1 Global Preclinical CRO Market Share by Application: 2017 VS 2021 VS 2028
- 1.3.2 Pharmaceutical Companies
- 1.3.3 Medical Device Companies
- 1.3.4 Others
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Preclinical CRO Market Perspective (2017-2028)
- 2.2 Preclinical CRO Growth Trends by Region
- 2.2.1 Preclinical CRO Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Preclinical CRO Historic Market Size by Region (2017-2022)
- 2.2.3 Preclinical CRO Forecasted Market Size by Region (2023-2028)
- 2.3 Preclinical CRO Market Dynamics
- 2.3.1 Preclinical CRO Industry Trends
- 2.3.2 Preclinical CRO Market Drivers
- 2.3.3 Preclinical CRO Market Challenges
- 2.3.4 Porter's Five Forces Analysis
3 Competition Landscape by Key Players
- 3.1 Global Top Preclinical CRO Players by Revenue
- 3.1.1 Global Top Preclinical CRO Players by Revenue (2019-2022)
- 3.1.2 Global Preclinical CRO Revenue Market Share by Players (2019-2022)
- 3.2 Global Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Preclinical CRO Revenue
- 3.4 Global Preclinical CRO Market Concentration Ratio
- 3.4.1 Global Preclinical CRO Market Concentration Ratio (CR5)
- 3.4.2 Global Top 10 and Top 5 Companies by Preclinical CRO Revenue in 2021
- 3.5 Preclinical CRO Key Players Head office and Area Served
- 3.6 Established Date of Preclinical CRO Players
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Preclinical CRO Breakdown Data by Type
- 4.1 Global Preclinical CRO Historic Market Size by Type (2017-2022)
- 4.2 Global Preclinical CRO Forecasted Market Size by Type (2023-2028)
5 Preclinical CRO Breakdown Data by Application
- 5.1 Global Preclinical CRO Historic Market Size by Application (2017-2022)
- 5.2 Global Preclinical CRO Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Preclinical CRO Market Size (2017-2028)
- 6.2 North America Preclinical CRO Market Size by Type
- 6.2.1 North America Preclinical CRO Market Size by Type (2017-2022)
- 6.2.2 North America Preclinical CRO Market Size by Type (2023-2028)
- 6.2.3 North America Preclinical CRO Market Share by Type (2017-2028)
- 6.3 North America Preclinical CRO Market Size by Application
- 6.3.1 North America Preclinical CRO Market Size by Application (2017-2022)
- 6.3.2 North America Preclinical CRO Market Size by Application (2023-2028)
- 6.3.3 North America Preclinical CRO Market Share by Application (2017-2028)
- 6.4 North America Preclinical CRO Market Size by Country
- 6.4.1 North America Preclinical CRO Market Size by Country (2017-2022)
- 6.4.2 North America Preclinical CRO Market Share by Country (2023-2028)
- 6.4.3 United States
- 6.4.4 Canada
7 Europe
- 7.1 Europe Preclinical CRO Market Size (2017-2028)
- 7.2 Europe Preclinical CRO Market Size by Type
- 7.2.1 Europe Preclinical CRO Market Size by Type (2017-2022)
- 7.2.2 Europe Preclinical CRO Market Size by Type (2023-2028)
- 7.2.3 Europe Preclinical CRO Market Share by Type (2017-2028)
- 7.3 Europe Preclinical CRO Market Size by Application
- 7.3.1 Europe Preclinical CRO Market Size by Application (2017-2022)
- 7.3.2 Europe Preclinical CRO Market Size by Application (2023-2028)
- 7.3.3 Europe Preclinical CRO Market Share by Application (2017-2028)
- 7.4 Europe Preclinical CRO Market Size by Country
- 7.4.1 Europe Preclinical CRO Market Size by Country (2017-2022)
- 7.4.2 Europe Preclinical CRO Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
8 Asia-Pacific
- 8.1 Asia-Pacific Preclinical CRO Market Size (2017-2028)
- 8.2 Asia-Pacific Preclinical CRO Market Size by Type
- 8.2.1 Asia-Pacific Preclinical CRO Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Preclinical CRO Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Preclinical CRO Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Preclinical CRO Market Size by Application
- 8.3.1 Asia-Pacific Preclinical CRO Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Preclinical CRO Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Preclinical CRO Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Preclinical CRO Market Size by Region
- 8.4.1 Asia-Pacific Preclinical CRO Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Preclinical CRO Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Preclinical CRO Market Size (2017-2028)
- 9.2 Latin America Preclinical CRO Market Size by Type
- 9.2.1 Latin America Preclinical CRO Market Size by Type (2017-2022)
- 9.2.2 Latin America Preclinical CRO Market Size by Type (2023-2028)
- 9.2.3 Latin America Preclinical CRO Market Share by Type (2017-2028)
- 9.3 Latin America Preclinical CRO Market Size by Application
- 9.3.1 Latin America Preclinical CRO Market Size by Application (2017-2022)
- 9.3.2 Latin America Preclinical CRO Market Size by Application (2023-2028)
- 9.3.3 Latin America Preclinical CRO Market Share by Application (2017-2028)
- 9.4 Latin America Preclinical CRO Market Size by Country
- 9.4.1 Latin America Preclinical CRO Market Size by Country (2017-2022)
- 9.4.2 Latin America Preclinical CRO Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Preclinical CRO Market Size (2017-2028)
- 10.2 Middle East & Africa Preclinical CRO Market Size by Type
- 10.2.1 Middle East & Africa Preclinical CRO Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Preclinical CRO Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Preclinical CRO Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Preclinical CRO Market Size by Application
- 10.3.1 Middle East & Africa Preclinical CRO Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Preclinical CRO Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Preclinical CRO Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Preclinical CRO Market Size by Country
- 10.4.1 Middle East & Africa Preclinical CRO Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Preclinical CRO Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Charles River
- 11.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.1.2 Preclinical CRO Product Overview
- 11.1.3 Charles River Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.1.4 Main Business/Business Overview
- 11.2 Wuxi AppTec
- 11.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.2.2 Preclinical CRO Product Overview
- 11.2.3 Wuxi AppTec Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.2.4 Main Business/Business Overview
- 11.3 Labcorp
- 11.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.3.2 Preclinical CRO Product Overview
- 11.3.3 Labcorp Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.3.4 Main Business/Business Overview
- 11.4 Eurofins Scientific
- 11.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.4.2 Preclinical CRO Product Overview
- 11.4.3 Eurofins Scientific Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.4.4 Main Business/Business Overview
- 11.5 PPD, Inc.
- 11.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.5.2 Preclinical CRO Product Overview
- 11.5.3 PPD, Inc. Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.5.4 Main Business/Business Overview
- 11.6 ICON Plc.
- 11.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.6.2 Preclinical CRO Product Overview
- 11.6.3 ICON Plc. Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.6.4 Main Business/Business Overview
- 11.7 Pharmaron
- 11.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.7.2 Preclinical CRO Product Overview
- 11.7.3 Pharmaron Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.7.4 Main Business/Business Overview
- 11.8 Inotiv
- 11.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.8.2 Preclinical CRO Product Overview
- 11.8.3 Inotiv Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.8.4 Main Business/Business Overview
- 11.9 ChemPartner
- 11.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.9.2 Preclinical CRO Product Overview
- 11.9.3 ChemPartner Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.9.4 Main Business/Business Overview
- 11.10 JOINN Lab
- 11.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.10.2 Preclinical CRO Product Overview
- 11.10.3 JOINN Lab Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.10.4 Main Business/Business Overview
- 11.11 EVOTEC
- 11.11.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.11.2 Preclinical CRO Product Overview
- 11.11.3 EVOTEC Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.11.4 Main Business/Business Overview
- 11.12 Medicilon
- 11.12.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.12.2 Preclinical CRO Product Overview
- 11.12.3 Medicilon Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.12.4 Main Business/Business Overview
- 11.13 Crown Bioscience
- 11.13.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.13.2 Preclinical CRO Product Overview
- 11.13.3 Crown Bioscience Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.13.4 Main Business/Business Overview
- 11.14 Champion Oncology
- 11.14.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
- 11.14.2 Preclinical CRO Product Overview
- 11.14.3 Champion Oncology Preclinical CRO Revenue (Million USD) and Gross Margin (%) (2019-2022)
- 11.14.4 Main Business/Business Overview
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Disclaimer
- 13.3 Author Details